EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Current Understanding of Pathogenic Mechanisms and Disease Models of Citrin Deficiency

Denis Lacabanne, Alice P Sowton, Bosco Jose, Edmund R S Kunji, Sotiria Tavoulari iD

Journal of Inherited Metabolic Disease · 2025

DOI: 10.1002/jimd.70021 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Inherited Metabolic Disease, 2025. Verfasst von Denis Lacabanne und 4 weiteren Autor:innen. Beteiligte Einrichtung: Medical Research Council Mitochondrial Biology Unit, University of Cambridge, Cambridge, UK. Hauptthemen laut MEDLINE: Citrullinemia, Calcium-Binding Proteins, Organic Anion Transporters. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 121 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Citrin Foundation, Biotechnology and Biological Sciences Research Council, MRF_.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Citrin deficiency (CD) is a complex mitochondrial disease with three different age‐related stages: neonatal intrahepatic cholestasis caused by CD (NICCD), failure to thrive and dyslipidemia caused by CD (FTTDCD), and type II citrullinemia (CTLN2), recently renamed adolescent and adult CD (AACD). While highly prevalent in the Asian population, CD is pan‐ethnic and remains severely underdiagnosed. The disease is caused by the dysfunction or absence of the mitochondrial aspartate/glutamate carrier 2 (AGC2/SLC25A13), also known as citrin. Citrin deficiency results in a direct impairment of the malate–aspartate shuttle and the urea cycle, with expected knock‐on effects on a multitude of other metabolic pathways, leading to a complicated pathophysiology. Here, we discuss our current knowledge of the molecular mechanism of substrate transport by citrin, including recent advances suggesting against its calcium regulation. We also discuss the different types of pathogenic variants found in CD patients and new insights into their pathogenic mechanisms. Additionally, we provide a summary and assessment of the efforts to develop preclinical models as well as treatments for the disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CitrullinemiaCalcium-Binding ProteinsOrganic Anion TransportersHumansAnimalsMitochondrial Membrane Transport ProteinsDisease Models, Animal

Stichwörter der Autor:innen

citrin deficiencydisease modelsmitochondrial transporturea cycle disorders

Substanzen

Mitochondrial Membrane Transport ProteinsCalcium-Binding ProteinsSLC25A13 protein, humanOrganic Anion Transporterscitrin

Autor:innen und Institutionen

  • Medical Research Council Mitochondrial Biology Unit, University of Cambridge, Cambridge, UK.

ORCID-Profile: Sotiria Tavoulari

Förderung

  • Citrin Foundation
  • Biotechnology and Biological Sciences Research Council
  • MRF_
  • Royal Perth Hospital Medical Research Foundation

Zitieren

APA

Lacabanne, D., Sowton, A. P., Jose, B., Kunji, E. R. S., & Tavoulari, S. (2025). Current Understanding of Pathogenic Mechanisms and Disease Models of Citrin Deficiency. Journal of Inherited Metabolic Disease. https://doi.org/10.1002/jimd.70021

Vancouver

Lacabanne D, Sowton AP, Jose B, Kunji ERS, Tavoulari S. Current Understanding of Pathogenic Mechanisms and Disease Models of Citrin Deficiency. Journal of Inherited Metabolic Disease. 2025. doi:10.1002/jimd.70021

BibTeX
@article{Lacabanne2025,
  author = {Lacabanne, Denis and Sowton, Alice P and Jose, Bosco and Kunji, Edmund R S and Tavoulari, Sotiria},
  title = {Current Understanding of Pathogenic Mechanisms and Disease Models of Citrin Deficiency},
  journal = {Journal of Inherited Metabolic Disease},
  year = {2025},
  doi = {10.1002/jimd.70021}
}
Kostenlos starten →